Muscle Building DSIP Peptides Delta Sleep Inducing CAS 62568-57-4 High Purity

 

 

Muscle Building DSIP Peptides Delta Sleep Inducing CAS 62568-57-4 High Purity Safe Pass

 

 

Abstract

DSIP is an amphiphilic peptide of molecular weight 850 daltons with the amino acid motif: N-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-C.

Delta sleep-inducing peptide, abbreviated DSIP, was first discovered in 1974 by the Swiss Schoenenberger-Monnier group who isolated it from the cerebral venous blood of rabbits in an induced state of sleep. It was primarily believed to be involved in sleep regulation due to its apparent ability to induce slow-wave sleep in rabbits, but studies on the subject have been contradictory.

It has been found in both free and bound forms in the hypothalamus, limbic system and pituitary as well as various peripheral organs, tissues and body fluids.[3] In the pituitary it co-localises with many peptide and non-peptide mediators such as corticotropin-like intermediate peptide (CLIP), adrenocorticotrophic hormone (ACTH), melanocyte-stimulating hormone (MSH), thyroid-stimulating hormone (TSH) and melanin concentrating hormone (MCH). It is abundant in the gut secretory cells and in the pancreas where it co-localises with glucagon.

 

Background And Objective

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that was first identified in the 1970s in studies focused on sleep regulation. It is primarily known for its ability to promote sleep, particularly deep sleep (slow-wave sleep), although its full range of physiological effects is still being explored. DSIP is a 8-amino acid peptide that is found in various tissues throughout the body, particularly in the brain, where it plays a key role in sleep regulation, but it is also involved in several other biological processes.

1. Discovery of DSIP

Initial Discovery:
DSIP was first discovered by researchers studying the mechanisms of sleep. The peptide was isolated from sleep-promoting substances in the brain, particularly during experiments involving sleep-deprived animals. Researchers observed that DSIP appeared to induce sleep, particularly deep, restorative sleep phases, which led to its initial classification as a sleep-inducing peptide.

Further Research:
In the years following its discovery, additional research was conducted to better understand the peptide's structure and mechanism of action. It was found to have a broader range of effects than initially thought, influencing not only sleep but also other physiological systems such as stress response, hormonal regulation, and pain modulation.

2. Objective of DSIP

The main objective of research on DSIP has been to understand its potential therapeutic uses, particularly in the following areas:

A. Sleep Regulation and Enhancement

Promoting Deep Sleep:
The primary function of DSIP, as its name suggests, is its ability to induce deep sleep. It is believed to help enhance the quality of slow-wave sleep (SWS), the deepest phase of non-rapid eye movement (NREM) sleep, which is critical for physical restoration, immune function, and memory consolidation.

Potential Use in Insomnia and Sleep Disorders:
Because of its effects on sleep, DSIP has been studied for potential use in treating sleep disorders, including insomnia, sleep apnea, and other sleep disturbances that involve disruptions in deep sleep cycles.

B. Hormonal Regulation

Impact on Hormones:
Research has shown that DSIP may influence hormonal release, including the regulation of growth hormone (GH) secretion. There is some evidence suggesting that DSIP can stimulate GH release, which is critical for muscle growth, tissue repair, and metabolism.

Stress and Cortisol:
DSIP may also modulate the stress response by affecting the release of cortisol, a hormone involved in the body's reaction to stress. Some studies suggest that DSIP could help balance cortisol levels, potentially mitigating chronic stress or improving the body's ability to recover from stress.

C. Neuroprotective and Anti-Stress Effects

Reducing Stress and Anxiety:
Preliminary studies suggest that DSIP might have neuroprotective properties, potentially protecting the brain from damage caused by oxidative stress or other neurological insults. Additionally, DSIP may help reduce anxiety and improve emotional regulation, though more research is needed to confirm these effects.

Regulation of the Hypothalamic-Pituitary-Adrenal Axis (HPA Axis):
The HPA axis is a central stress-response system that controls the release of various hormones, including cortisol. DSIP's influence on this axis may be important for its potential to alleviate stress and improve overall mental well-being.

D. Pain Modulation

Potential Analgesic Effects:
DSIP has shown some promise in the modulation of pain. Certain animal studies have suggested that DSIP might help alleviate pain, possibly through its interactions with the endogenous opioid system or other mechanisms in the nervous system.

Chronic Pain Management:
Given the peptide's possible analgesic effects, there is interest in studying DSIP as a treatment for chronic pain conditions, including neuropathic pain or musculoskeletal pain.

E. Reproductive and Immune System Effects

Reproductive Function:
Some studies have suggested that DSIP might be involved in regulating the reproductive system, although this area of research is still in its early stages. Its effects on hormonal regulation may influence fertility, menstrual cycles, or other reproductive processes.

Immune System Modulation:
DSIP may also have a role in modulating the immune system, particularly in the context of immune response and inflammation. Research is still ongoing to understand the full extent of DSIP's role in immune function.

3. Summary of DSIP's Objectives in Research

In summary, the primary objectives of research on Delta Sleep-Inducing Peptide (DSIP) are:

To enhance and regulate sleep by promoting deep sleep, which is vital for overall health and recovery.

To improve hormonal balance, particularly the regulation of growth hormone, stress hormones (such as cortisol), and potentially reproductive hormones.

To reduce stress and anxiety, making DSIP a potential therapeutic agent for mood regulation and stress management.

To modulate pain, with possible analgesic benefits for chronic pain or neuropathic conditions.

To investigate its neuroprotective properties and possible benefits for cognitive health and brain function.

To study its influence on the immune system and its potential applications in treating inflammation or immune-related disorders.

 

 

Function

Many roles for DSIP have been suggested following research carried out using peptide analogues with a greater molecular stability and through measuring DSIP-like immunological (DSIP-LI) response by injecting DSIP antiserum and antibodies.

Roles In Endocrine Regulation

Decreases basal corticotropin level and blocks its release.
Stimulates release of luteinizing hormone (LH).
Stimulates release of somatoliberin and somatotrophin secretion and inhibits somatostatin secretion.

 

 

 

High purity Polypeptides